Longitudinally Extensive Transverse Myelitis: One Disease, Variable Outcomes-A Case Series
Shyam Chandrasekar1, Joseph John1, Amit Kumar Satapathy1
1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Journal of Neurosciences in Rural Practice
|June 13, 2022
Summary
Longitudinal extensive transverse myelitis (LETM) is a rare spinal cord inflammation with varied symptoms and causes. Early immunomodulatory therapy may improve outcomes in children with LETM.
Area of Science:
- Neurology
- Pediatrics
- Immunology
Background:
- Longitudinal extensive transverse myelitis (LETM) is a rare, severe spinal cord inflammation.
- LETM presents acutely with sensory, motor, and autonomic dysfunction, often with poor prognosis.
- Pediatric LETM cases exhibit diverse clinical presentations and etiologies.
Purpose of the Study:
- To present a case series of three children diagnosed with LETM.
- To highlight the varied clinical manifestations and diagnostic challenges of pediatric LETM.
- To discuss the role of immunomodulatory therapies in managing LETM.
Main Methods:
- Case series analysis of three pediatric patients (ages 4-13) with LETM.
- Clinical assessment, neurological examination, and contrast-enhanced MRI spine were performed.
- Treatment involved pulsed dose methylprednisolone, intravenous immunoglobulin, and oral prednisolone.
Main Results:
- Patients presented with diverse symptoms including vision loss, seizures, abdominal pain, urinary retention, constipation, and limb weakness.
- Spinal MRI revealed long segment T2 hyperintensity in all cases, with some brain involvement.
- Two of three children showed faster recovery with early immunomodulatory treatment.
Conclusions:
- LETM in children has varied presentations and etiologies.
- Testing for Aquaporin-4 IgG and anti-myelin oligodendrocyte glycoprotein antibodies is recommended.
- Prompt and aggressive immunomodulatory therapy can facilitate recovery in pediatric LETM.


